Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biochim Biophys Acta Proteins Proteom ; 1869(1): 140555, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33068755

RESUMO

Gyrate Atrophy (GA) of the choroid and retina (MIM# 258870) is an autosomal recessive disorder due to mutations of the OAT gene encoding ornithine-delta-aminotransferase (OAT), associated with progressive retinal deterioration and blindness. The disease has a theoretical global incidence of approximately 1:1,500,000. OAT is mainly involved in ornithine catabolism in adults, thus explaining the hyperornithinemia as hallmark of the disease. Patients are treated with an arginine-restricted diet, to limit ornithine load, or the administration of Vitamin B6, a precursor of the OAT coenzyme pyridoxal phosphate. Although the clinical and genetic aspects of GA are known for many years, the enzymatic phenotype of pathogenic variants and their response to Vitamin B6, as well as the molecular mechanisms explaining retinal damage, are poorly clarified. Herein, we provide an overview of the current knowledge on the biochemical properties of human OAT and on the molecular, cellular, and clinical aspects of GA.


Assuntos
Coenzimas/administração & dosagem , Atrofia Girata/dietoterapia , Atrofia Girata/enzimologia , Ornitina-Oxo-Ácido Transaminase/deficiência , Fosfato de Piridoxal/administração & dosagem , Vitamina B 6/administração & dosagem , Arginina/metabolismo , Corioide/enzimologia , Corioide/patologia , Cromossomos Humanos Par 10 , Dieta/métodos , Expressão Gênica , Atrofia Girata/genética , Atrofia Girata/patologia , Humanos , Modelos Moleculares , Mutação , Ornitina/metabolismo , Ornitina-Oxo-Ácido Transaminase/química , Ornitina-Oxo-Ácido Transaminase/genética , Multimerização Proteica , Estrutura Secundária de Proteína , Retina/enzimologia , Retina/patologia
2.
Biochem Med (Zagreb) ; 28(3): 030801, 2018 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-30429681

RESUMO

Gyrate atrophy (GA) of the choroid and retina is a rare autosomal recessive disorder that occurs due to deficiency of the mitochondrial enzyme ornithine aminotransferase (OAT). Hyperornithinemia causes degeneration of the retina with symptoms like myopia, reduced night vision and progressive vision loss. Our patient is a 10-year-old girl with impaired vision and strabismus. As part of the metabolic work-up, plasma amino acid analysis revealed significantly increased concentration of ornithine (1039 µmol/L; reference interval 20 - 155 µmol/L). Molecular genetic analysis revealed homozygous mutation in exon 7 of the OAT gene that has not been reported previously (c.868_870delCTT p.(Leu290del)). This in frame deletion was predicted to be deleterious by in silico software analysis. Our patient was treated with pyridoxine (vitamin B6 in a dose of 2 x 100 mg/day), low-protein diet (0.6 g/kg/day) and L-lysine supplementation which resulted in a significant reduction in plasma ornithine concentrations to 53% of the initial concentration and the ophthalmologic findings showed significant improvement. We conclude that low protein diet and lysine supplementation can lead to long-term reduction in plasma ornithine concentrations and, if started at an early age, notably slow the progression of retinal function loss in patients with GA. The effect of therapy can be reliably monitored by periodical measurement of plasma ornithine concentration. To our knowledge, this is the first report of OAT deficiency in Croatia.


Assuntos
Atrofia Girata/genética , Mutação , Ornitina-Oxo-Ácido Transaminase/genética , Contagem de Células Sanguíneas , Criança , Croácia , Feminino , Angiofluoresceinografia , Seguimentos , Atrofia Girata/sangue , Atrofia Girata/diagnóstico por imagem , Atrofia Girata/enzimologia , Humanos , Tomografia de Coerência Óptica
3.
Biochimie ; 119: 146-65, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26542286

RESUMO

Creatine is physiologically provided equally by diet and by endogenous synthesis from arginine and glycine with successive involvements of arginine glycine amidinotransferase [AGAT] and guanidinoacetate methyl transferase [GAMT]. A specific plasma membrane transporter, creatine transporter [CRTR] (SLC6A8), further enables cells to incorporate creatine and through uptake of its precursor, guanidinoacetate, also directly contributes to creatine biosynthesis. Breakthrough in the role of creatine has arisen from studies on creatine deficiency disorders. Primary creatine disorders are inherited as autosomal recessive (mutations affecting GATM [for glycine-amidinotransferase, mitochondrial]) and GAMT genes) or X-linked (SLC6A8 gene) traits. They have highlighted the role of creatine in brain functions altered in patients (global developmental delay, intellectual disability, behavioral disorders). Creatine modulates GABAergic and glutamatergic cerebral pathways, presynaptic CRTR (SLC6A8) ensuring re-uptake of synaptic creatine. Secondary creatine disorders, addressing other genes, have stressed the extraordinary imbrication of creatine metabolism with many other cellular pathways. This high dependence on multiple pathways supports creatine as a cellular sensor, to cell methylation and energy status. Creatine biosynthesis consumes 40% of methyl groups produced as S-adenosylmethionine, and creatine uptake is controlled by AMP activated protein kinase, a ubiquitous sensor of energy depletion. Today, creatine is considered as a potential sensor of cell methylation and energy status, a neurotransmitter influencing key (GABAergic and glutamatergic) CNS neurotransmission, therapeutic agent with anaplerotic properties (towards creatine kinases [creatine-creatine phosphate cycle] and creatine neurotransmission), energetic and antioxidant compound (benefits in degenerative diseases through protection against energy depletion and oxidant species) with osmolyte behavior (retention of water by muscle). This review encompasses all these aspects by providing an illustrated metabolic account for brain and body creatine in health and disease, an algorithm to diagnose metabolic and gene bases of primary and secondary creatine deficiencies, and a metabolic exploration by (1)H-MRS assessment of cerebral creatine levels and response to therapeutic measures.


Assuntos
Amidinotransferases/metabolismo , Creatina/metabolismo , Guanidinoacetato N-Metiltransferase/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Proteínas da Membrana Plasmática de Transporte de Neurotransmissores/metabolismo , Proteínas Quinases Ativadas por AMP/metabolismo , Amidinotransferases/deficiência , Amidinotransferases/genética , Erros Inatos do Metabolismo dos Aminoácidos/diagnóstico , Erros Inatos do Metabolismo dos Aminoácidos/enzimologia , Erros Inatos do Metabolismo dos Aminoácidos/genética , Erros Inatos do Metabolismo dos Aminoácidos/metabolismo , Sistemas de Transporte de Aminoácidos Básicos/deficiência , Sistemas de Transporte de Aminoácidos Básicos/genética , Sistemas de Transporte de Aminoácidos Básicos/metabolismo , Animais , Transporte Biológico Ativo , Encefalopatias Metabólicas Congênitas/diagnóstico , Encefalopatias Metabólicas Congênitas/enzimologia , Encefalopatias Metabólicas Congênitas/genética , Encefalopatias Metabólicas Congênitas/metabolismo , Creatina/biossíntese , Creatina/deficiência , Creatina/genética , Deficiências do Desenvolvimento/diagnóstico , Deficiências do Desenvolvimento/enzimologia , Deficiências do Desenvolvimento/genética , Deficiências do Desenvolvimento/metabolismo , Metabolismo Energético , Guanidinoacetato N-Metiltransferase/deficiência , Guanidinoacetato N-Metiltransferase/genética , Atrofia Girata/diagnóstico , Atrofia Girata/enzimologia , Atrofia Girata/genética , Atrofia Girata/metabolismo , Humanos , Hiperamonemia/diagnóstico , Hiperamonemia/enzimologia , Hiperamonemia/genética , Hiperamonemia/metabolismo , Deficiência Intelectual/diagnóstico , Deficiência Intelectual/enzimologia , Deficiência Intelectual/genética , Deficiência Intelectual/metabolismo , Transtornos do Desenvolvimento da Linguagem/diagnóstico , Transtornos do Desenvolvimento da Linguagem/enzimologia , Transtornos do Desenvolvimento da Linguagem/genética , Transtornos do Desenvolvimento da Linguagem/metabolismo , Deficiência Intelectual Ligada ao Cromossomo X/diagnóstico , Deficiência Intelectual Ligada ao Cromossomo X/enzimologia , Deficiência Intelectual Ligada ao Cromossomo X/genética , Deficiência Intelectual Ligada ao Cromossomo X/metabolismo , Metilação , Proteínas de Transporte da Membrana Mitocondrial , Transtornos dos Movimentos/congênito
4.
Doc Ophthalmol ; 128(2): 137-48, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24429551

RESUMO

BACKGROUND: Gyrate atrophy (GA) of the choroid and retina is an extremely rare inherited chorioretinal dystrophy. Ornithine aminotransferase (OAT) gene mutations are identified in patients with GA. The purpose of this study was to report a novel deletion mutation of the OAT gene and describe clinical features of two brothers with GA in a Japanese family. METHODS: We performed ophthalmic examinations, including best-corrected visual acuity, slit-lamp biomicroscopy, dilated funduscopy, fundus autofluorescence imaging, optical coherence tomography, visual field testing, and full-field electroretinography (ERG). Serum ornithine concentrations and OAT activities were analyzed. Mutation screening of the OAT gene was performed using Sanger sequencing. RESULTS: Both brothers had compound heterozygous mutations (p.K169DfsX10 and p.R426X), one of which was novel. Their unaffected parents carried one of the mutations heterozygously. An arginine-restricted diet was started in the younger brother at the age of 2 years, while the diet was not initiated in the older brother until the age of 6 years. After more than 15 years of follow-up, the dietary treatment seemed to slow the progression of the chorioretinal lesions in the younger brother. However, when compared at the same age, the younger brother had more reduced ERG amplitudes and constricted visual fields than his older brother. CONCLUSIONS: We identified a novel frameshift mutation (p.K169DfsX10) in the OAT gene. While an early arginine-restricted dietary treatment suppressed the fundus changes of GA to some degree in the younger brother, the efficacy of suppressing the progression of visual function loss could not be clearly determined.


Assuntos
Mutação da Fase de Leitura , Atrofia Girata/diagnóstico , Atrofia Girata/genética , Ornitina-Oxo-Ácido Transaminase/genética , Povo Asiático/genética , Atrofia , Criança , Corioide/patologia , Eletrorretinografia , Atrofia Girata/dietoterapia , Atrofia Girata/enzimologia , Humanos , Lactente , Masculino , Ornitina/sangue , Ornitina-Oxo-Ácido Transaminase/sangue , Linhagem , Reação em Cadeia da Polimerase , Retina/patologia , Irmãos , Tomografia de Coerência Óptica , Acuidade Visual/fisiologia , Testes de Campo Visual , Campos Visuais
5.
Korean J Ophthalmol ; 27(5): 388-91, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24082780

RESUMO

A pair of 19-year-old female identical twins was referred to our hospital with progressive visual loss. They exhibited bilateral chorioretinal atrophy involving the midperiphery on fundoscopy and fluorescein angiography. Bilateral visual field constriction was noted on dynamic Goldmann perimetry, and a markedly impaired response was observed on both photopic and scotopic electroretinograms. Cystoid macular edema was identified in both eyes on optical coherence tomography. Plasma levels of ornithine were elevated. Based on these observations, the patients were diagnosed with gyrate atrophy of the choroid and retina. The clinical diagnosis was confirmed by mutation analysis of the ornithine-δ-aminotransferase (OAT) gene. Patients were treated with a pyridoxine supplement (300 mg/day) and an arginine-restricted diet to lower plasma levels of ornithine, which were successfully reduced without progression of chorioretinal atrophy for 15 months. Our report describes the first case of gyrate atrophy in the Korean population diagnosed by OAT gene analysis and treated with vitamin B6 dietary supplementation.


Assuntos
DNA/análise , Atrofia Girata/diagnóstico , Mutação , Ornitina-Oxo-Ácido Transaminase/genética , Análise Mutacional de DNA , Diagnóstico Diferencial , Eletrorretinografia , Feminino , Angiofluoresceinografia , Fundo de Olho , Atrofia Girata/enzimologia , Atrofia Girata/genética , Humanos , Ornitina-Oxo-Ácido Transaminase/metabolismo , Tomografia de Coerência Óptica , Acuidade Visual , Adulto Jovem
6.
Hum Mutat ; 34(1): 229-36, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23076989

RESUMO

We studied eight kindreds with gyrate atrophy of choroid and retina (GA), a rare autosomal recessive disorder caused by mutations of the OAT gene, encoding the homoexameric enzyme ornithine-delta-aminotransferase. We identified four novel and five previously reported mutations. Missense alleles were expressed in yeast strain carrying a deletion of the orthologous of human OAT. All mutations markedly reduced enzymatic activity. However, the effect on the yeast growth was variable, suggesting that some mutations retain residual activity, below the threshold of the enzymatic assay. Mutant proteins were either highly unstable and rapidly degraded, or failed to assemble to form the active OAT hexamer. Where possible, fibroblast analysis confirmed these data. We found no correlation between the residual enzymatic activity and the age of onset, or the severity of symptoms. Moreover, the response to B6 was apparently not related to the specific mutations carried by patients. Overall these data suggest that other factors besides the specific OAT genotype modulate (GA) phenotype in patients. Finally, we found that 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), an AMPK activator known to increase mitochondrial biogenesis, markedly stimulates OAT expression, thus representing a possible treatment for a subset of GA patients with hypomorphic alleles.


Assuntos
Predisposição Genética para Doença/genética , Atrofia Girata/genética , Mutação de Sentido Incorreto , Ornitina-Oxo-Ácido Transaminase/genética , Sequência de Aminoácidos , Aminoimidazol Carboxamida/análogos & derivados , Aminoimidazol Carboxamida/farmacologia , Células Cultivadas , Análise Mutacional de DNA , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Teste de Complementação Genética , Genótipo , Atrofia Girata/enzimologia , Atrofia Girata/patologia , Células HEK293 , Humanos , Immunoblotting , Modelos Moleculares , Dados de Sequência Molecular , Ornitina-Oxo-Ácido Transaminase/química , Ornitina-Oxo-Ácido Transaminase/metabolismo , Fenótipo , Estrutura Terciária de Proteína , Ribonucleotídeos/farmacologia , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/crescimento & desenvolvimento , Homologia de Sequência de Aminoácidos
7.
Ophthalmology ; 119(3): 596-605, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22182799

RESUMO

PURPOSE: To describe phenotypic variability and to report novel mutational data in patients with gyrate atrophy. DESIGN: Retrospective case series. PARTICIPANTS: Seven unrelated patients (10 to 52 years of age) with clinical and biochemical evidence of gyrate atrophy. METHODS: Detailed ophthalmologic examination, fundus photography, fundus autofluorescence (FAF) imaging, spectral-domain optical coherence tomography, and microperimetry testing were performed. The coding region and intron-exon boundaries of ornithine aminotransferase (OAT) were analyzed. OAT mRNA was isolated from peripheral blood leucocytes of 1 patient and analyzed. MAIN OUTCOME MEASURES: OAT mutation status and resultant clinical, structural, and functional characteristics. RESULTS: Funduscopy revealed circular areas of chorioretinal atrophy, and FAF imaging showed sharply demarcated areas of increased or preserved signal in all 7 patients. Spectral-domain optical coherence tomography revealed multiple intraretinal cystic spaces and hyperreflective deposit in the ganglion cell layer of all study subjects. Round tubular, rosette-like structures located in the outer nuclear layer of the retinae of the 4 older patients were observed (termed outer retinal tubulation). Thickening was evident in the foveolae of younger patients, despite the posterior pole appearing relatively preserved. Macular function, assessed by microperimetry, was preserved over areas of normal or increased autofluorescence. However, sensitivity was reduced even in structurally intact parts of the retina. The molecular pathologic features were determined in all study subjects: 9 mutations, 4 novel, were detected in the OAT gene. OAT mRNA was isolated from blood leukocytes, and monoallelic expression of a mutated allele was demonstrated in 1 patient. CONCLUSIONS: Fundus autofluorescence imaging can reveal the extent of neurosensory dysfunction in gyrate atrophy patients. Macular edema is a uniform finding; the fovea is relatively thick in early stages of disease and retinal tubulation is present in advanced disease. Analysis of leukocyte RNA complements the high sensitivity of conventional sequencing of genomic DNA for mutation detection in this gene.


Assuntos
Atrofia Girata/genética , Atrofia Girata/fisiopatologia , Ornitina-Oxo-Ácido Transaminase/genética , Retina/fisiopatologia , Adolescente , Adulto , Criança , Biologia Computacional , Sensibilidades de Contraste/fisiologia , Análise Mutacional de DNA , Feminino , Angiofluoresceinografia , Atrofia Girata/enzimologia , Humanos , Masculino , Pessoa de Meia-Idade , Mutação de Sentido Incorreto , Oftalmoscopia , Ornitina-Oxo-Ácido Transaminase/sangue , Fenótipo , RNA Mensageiro/genética , Retina/enzimologia , Estudos Retrospectivos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Tomografia de Coerência Óptica , Acuidade Visual/fisiologia , Testes de Campo Visual , Campos Visuais
8.
Proc Natl Acad Sci U S A ; 108(16): 6537-42, 2011 Apr 19.
Artigo em Inglês | MEDLINE | ID: mdl-21464322

RESUMO

Gene-corrected patient-specific induced pluripotent stem (iPS) cells offer a unique approach to gene therapy. Here, we begin to assess whether the mutational load acquired during gene correction of iPS cells is compatible with use in the treatment of genetic causes of retinal degenerative disease. We isolated iPS cells free of transgene sequences from a patient with gyrate atrophy caused by a point mutation in the gene encoding ornithine-δ-aminotransferase (OAT) and used homologous recombination to correct the genetic defect. Cytogenetic analysis, array comparative genomic hybridization (aCGH), and exome sequencing were performed to assess the genomic integrity of an iPS cell line after three sequential clonal events: initial reprogramming, gene targeting, and subsequent removal of a selection cassette. No abnormalities were detected after standard G-band metaphase analysis. However, aCGH and exome sequencing identified two deletions, one amplification, and nine mutations in protein coding regions in the initial iPS cell clone. Except for the targeted correction of the single nucleotide in the OAT locus and a single synonymous base-pair change, no additional mutations or copy number variation were identified in iPS cells after the two subsequent clonal events. These findings confirm that iPS cells themselves may carry a significant mutational load at initial isolation, but that the clonal events and prolonged cultured required for correction of a genetic defect can be accomplished without a substantial increase in mutational burden.


Assuntos
Atrofia Girata/enzimologia , Atrofia Girata/genética , Ornitina-Oxo-Ácido Transaminase/genética , Ornitina-Oxo-Ácido Transaminase/metabolismo , Células-Tronco Pluripotentes/enzimologia , Células Cultivadas , Marcação de Genes/métodos , Estudo de Associação Genômica Ampla , Instabilidade Genômica/genética , Atrofia Girata/patologia , Atrofia Girata/terapia , Humanos , Células-Tronco Pluripotentes/patologia , Recombinação Genética
9.
Ophthalmology ; 108(4): 721-9, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11297489

RESUMO

OBJECTIVE/PURPOSE: To investigate clinical variation in a genetically homogenous group of subjects with gyrate atrophy of choroid and retina with hyperornithinemia (GA). The group was made up of homozygotes and compound heterozygotes for mutation L402P in the ornithine aminotransferase (OAT) gene. DESIGN: Cross-sectional study. PARTICIPANTS: Thirty-five Finnish subjects (18 men) with GA with a mean age of 33 years (range, 5-74 years) carrying the Finnish founder mutation L402P. METHODS: All subjects were examined between 1993 and 1995. The analysis was composed of, in addition to careful clinical evaluation, studies of visual fields with Goldmann perimeter, photographing of the eye fundi, and corneal electroretinography (ERG) recordings. MAIN OUTCOME MEASURES: The changes in eye fundi, visual acuity, cataract changes in the lens, visual field constriction, and ERG responses were determined. RESULTS: Myopia, early cataracts, and highly abnormal ERG were typical for the GA subjects. The changes progressed rather uniformly with age. However, visual acuity, funduscopic findings, and visual fields showed great phenotypic variation. Despite the great interindividual variation, both eyes of each subject were always similarly affected. CONCLUSIONS: This study of 35 subjects with GA carrying a single mutation shows that the ophthalmologic symptoms and findings vary widely. The data also reveal that GA subjects are already affected by severe visual impairment in young adulthood. However, the diagnosis is often made very late.


Assuntos
Corioide/patologia , Heterogeneidade Genética , Atrofia Girata/genética , Mutação , Ornitina-Oxo-Ácido Transaminase/genética , Retina/patologia , Adolescente , Adulto , Catarata/diagnóstico , Criança , Pré-Escolar , Estudos Transversais , Eletrorretinografia , Feminino , Genótipo , Atrofia Girata/sangue , Atrofia Girata/enzimologia , Atrofia Girata/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Miopia/diagnóstico , Ornitina/sangue , Acuidade Visual , Testes de Campo Visual , Campos Visuais
10.
Clin Chim Acta ; 296(1-2): 91-100, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10807973

RESUMO

A deficiency of the mitochondrial matrix enzyme L-ornithine: 2-oxoacid aminotransferase causes gyrate atrophy of the choroid and retina with hyperornithinemia (MIM 258870), a blinding degenerative disease, which is inherited as an autosomal recessive trait. We have developed a sensitive microradioisotopic method for enzyme assay by using 2-oxo-[5-14C] glutarate as the substrate and performing the separation of the product, [5-14C] glutamate from the substrate on a cation-exchange column. The enzyme activity was determined in human and rat tissues and in cultured cells. The enzyme activity in fibroblasts from a patient was deficient and that of the parents ranged between 25 and 60% of the control values. In addition we have found the enzyme expressed in native and cultured chorionic villi indicating a potential detection of the disease during the first trimester of pregnancy.


Assuntos
Amostra da Vilosidade Coriônica , Atrofia Girata/diagnóstico , Atrofia Girata/enzimologia , Ornitina-Oxo-Ácido Transaminase/deficiência , Ornitina-Oxo-Ácido Transaminase/metabolismo , Animais , Células Cultivadas , Vilosidades Coriônicas/enzimologia , Feminino , Fibroblastos/enzimologia , Humanos , Fígado/enzimologia , Masculino , Músculo Esquelético/enzimologia , Gravidez , Primeiro Trimestre da Gravidez , Ratos
11.
Pediatr Res ; 44(3): 381-5, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9727717

RESUMO

Deficiency of omithine-delta-aminotransferase (OAT) causes gyrate atrophy of the choroid and retina with hyperornithinemia (GA; McKusick 258870), a progressive autosomal recessive chorioretinal degeneration leading to early blindness. As residual enzyme activity may vary in different mutations of the OAT gene and explain individual variations in disease progression, a sensitive HPLC modification of the OAT assay in lymphocytes was developed, based on measurement of the dihydroquinozolinium reaction product. The OAT activities (ranges) of 43 Finnish GA patients with mutations L402P/L402P, R180T/L402P, N89K/ L402P, and L402P/x (x = previously unknown allele), were <1-10, <1-13, <1-17, and <1 pmol x min(-1) mg protein(-1), respectively. The OAT activities (mean+/-SD) of nine L402P/ wild heterozygotes were 70+/-50 (range 33-193), and those of 15 healthy control subjects 184+/-60 (range 85-291) pmol x min(-1) mg protein(-1). This lymphocyte assay is an easy, rapid, and sensitive method for reliable recognition of GA homozygotes. OAT mutations of the Finnish patients show similar residual enzyme activity in the lymphocytes. OAT activities in the L402P heterozygotes and healthy control subjects overlap, suggesting that, for reliable carrier detection, the OAT alleles have to be studied. However, as all OAT mutations are not known, direct measurement of enzyme activity has a role in heterozygote identification and possibly also in prenatal diagnosis of GA.


Assuntos
Atrofia Girata/enzimologia , Linfócitos/enzimologia , Ornitina-Oxo-Ácido Transaminase/sangue , Adolescente , Adulto , Criança , Pré-Escolar , Ativação Enzimática , Atrofia Girata/sangue , Atrofia Girata/genética , Humanos , Lactente , Mutação , Ornitina-Oxo-Ácido Transaminase/genética
12.
Hum Gene Ther ; 8(17): 2125-32, 1997 Nov 20.
Artigo em Inglês | MEDLINE | ID: mdl-9414260

RESUMO

Gyrate atrophy is a progressive blindness associated with deficiency of ornithine aminotransferase (OAT). The strategy of using an autologous keratinocyte graft, modified to express high levels of OAT as an ornithine-catabolizing skin-based enzyme sink, is investigated. Two OAT-containing retroviral vectors were constructed with or without a resistance gene. When packaged in a retroviral vector particle generated with the gibbon ape leukemia (GALV) virus envelope (PG13), these vectors could readily transduce >50% of target keratinocytes. The transduced keratinocytes in culture expressed up to 75-fold more OAT than normal control keratinocytes and these gene-modified cells extracted [14C]ornithine more efficiently than controls. The vector prepared without neo transduced cells more efficiently and led to higher levels of OAT expression than the neo-containing vector. Ornithine catabolism was maintained at high levels when the transduced patient keratinocytes were differentiated in vitro as a multilayered cutaneous organoid.


Assuntos
Técnicas de Transferência de Genes , Vetores Genéticos , Atrofia Girata/enzimologia , Queratinócitos/metabolismo , Vírus da Leucemia do Macaco Gibão/genética , Ornitina-Oxo-Ácido Transaminase/genética , Células 3T3 , Animais , Terapia Genética , Atrofia Girata/terapia , Humanos , Camundongos , Ornitina-Oxo-Ácido Transaminase/deficiência , Ornitina-Oxo-Ácido Transaminase/metabolismo
13.
Structure ; 5(8): 1067-75, 1997 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-9309222

RESUMO

BACKGROUND: Ornithine aminotransferase (OAT) is a 45 kDa pyridoxal-5'-phosphate (PLP)-dependent enzyme that catalyzes the conversion of L-ornithine and 2-oxoglutarate to glutamate-delta-semialdehyde and glutamic acid, respectively. In humans, loss of OAT function causes an accumulation of ornithine that results in gyrate atrophy of the choroid and retina, a disease that progressively leads to blindness. In an effort to learn more about the structural basis of this enzyme's function, we have determined the X-ray structures of OAT in complex with two enzyme-activated suicide substrates: L-canaline, an ornithine analog, and gabaculine, an irreversible inhibitor of several related aminotransferases. RESULTS: The structures of human OAT bound to the inhibitors gabaculine and L-canaline were solved to 2.3 A at 110K by difference Fourier techniques. Both inhibitors coordinate similarly in the active site, binding covalently to the PLP cofactor and causing a 20 degrees rotation in the cofactor tilt relative to the ligand-free form. Aromatic-aromatic interactions occur between the bound gabaculine molecule and active-site residues Tyr85 and Phe177, whereas Tyr55 and Arg180 provide specific contacts to the alpha-amino and carboxyl groups of L-canaline. CONCLUSIONS: The OAT-L-canaline complex structure implicates Tyr55 and Arg180 as the residues involved in coordinating with the natural substrate ornithine during normal enzyme turnover. This correlates well with two enzyme-inactivating point mutations associated with gyrate atrophy, Tyr55-->His and Arg180-->Thr. The OAT-gabaculine complex provides the first structural evidence that the potency of the inhibitor is due to energetically favourable aromatic interactions with residues in the active site. This aromatic-binding mode may be relevant to structure-based drug design efforts against other omega-aminotransferase targets, such as GABA aminotransferase.


Assuntos
Aminobutiratos/química , Ácidos Cicloexanocarboxílicos/química , Ornitina-Oxo-Ácido Transaminase/química , Arginina/química , Sítios de Ligação , Cristalografia por Raios X , Inibidores Enzimáticos , Atrofia Girata/enzimologia , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Ornitina-Oxo-Ácido Transaminase/genética , Fosfato de Piridoxal/química , Transaminases/antagonistas & inibidores , Tirosina/química
14.
Curr Eye Res ; 15(7): 792-6, 1996 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8670789

RESUMO

PURPOSE: To identify mutations in ornithine aminotransferase (OAT) in seven Japanese families with gyrate atrophy (GA), an autosomal recessive chorioretinal degeneration of the eye caused by a generalized biochemical deficiency in OAT; mutations in the OAT gene have shown a high degree of molecular heterogeneity. METHODS: DNA was prepared from patients' fibroblasts and analyzed by polymerase-chain-reaction amplification of the OAT gene sequence, denaturing gradient gel electrophoresis, and direct sequencing for identification of the mutations. RESULTS: Eight different mutations were identified in seven unrelated Japanese GA patients with hyperornithinemia, confirming the high genetic heterogeneity of this disease. Five of these mutations were new, including one causing a pyridoxine-responsive disease, and all eight mutations have been found only in Japanese GA patients. Consistent with some similarity between the Japanese and Finnish populations in genetic isolation and homogeneity, there was a preponderance of homozygous mutations (five out of seven patients) as was previously reported for 16 Finnish GA pedigrees. CONCLUSION: The eight Japanese OAT mutations represent a group of heterogenous mutations unique to a specific population pool.


Assuntos
Atrofia Girata/enzimologia , Atrofia Girata/genética , Mutação , Ornitina-Oxo-Ácido Transaminase/genética , Sequência de Aminoácidos , Sequência de Bases , Códon/genética , Heterozigoto , Homozigoto , Humanos , Japão , Ornitina-Oxo-Ácido Transaminase/deficiência , Mutação Puntual , Deleção de Sequência
15.
Am J Hum Genet ; 56(3): 616-22, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7887415

RESUMO

We discovered the missense mutation, A226V, in the ornithine-delta-aminotransferase (OAT) genes of two unrelated patients with gyrate atrophy of the choroid and retina (GA). One patient, who was a compound for A226V and for the premature termination allele R398ter, showed a significant (P < .01) decrease in mean plasma ornithine levels, following pyridoxine supplementation with a constant protein intake: 826 +/- 128 microM (n = 5; no pyridoxine supplementation) versus 504 +/- 112 microM (n = 6; 500 mg pyridoxine/d) and 546 +/- 19 microM (n = 6; 1,000 mg pyridoxine/d). In extracts of fibroblasts from a second GA patient homozygous for A226V and from Chinese hamster ovary cells expressing an OAT-cDNA-containing A226V, we found that OAT activity increased from undetectable levels to approximately 10% of normal when the concentration of pyridoxal phosphate was increased from 50 to 600 microM. A226V is the fourth disease-causing pyridoxine-responsive human mutation to be reported.


Assuntos
Atrofia Girata/genética , Mutação , Piridoxina/uso terapêutico , Sequência de Aminoácidos , Animais , Sequência de Bases , Células CHO , Células Cultivadas , Criança , Cricetinae , Cricetulus , Éxons , Feminino , Fibroblastos/enzimologia , Atrofia Girata/tratamento farmacológico , Atrofia Girata/enzimologia , Humanos , Dados de Sequência Molecular , Ornitina-Oxo-Ácido Transaminase/genética , Reação em Cadeia da Polimerase , Polimorfismo Conformacional de Fita Simples
16.
Invest Ophthalmol Vis Sci ; 35(3): 1065-70, 1994 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8125717

RESUMO

PURPOSE: A generalized biochemical deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (OAT) is the inborn error in gyrate atrophy (GA), an autosomal recessive blinding disease of the retina and choroid of the eye. Because mutations in the OAT gene show a high degree of molecular heterogeneity in GA, the authors set out to determine the mutations by rapid and efficient methods. METHODS: The mutations in the OAT gene were determined by a combination of polymerase chain reaction (PCR) amplification of gene sequences, analysis by denaturing gradient gel electrophoresis (DGGE), and direct DNA sequencing. RESULTS: Eleven different mutations in 21 (95.5%) out of 22 mutant OAT alleles from 11 patients were identified: six missense mutations, three nonsense mutations, one 2 bp-deletion, and one splice acceptor mutation. A silent polymorphism of Asn (AAC)378 to Asn (AAT) was also observed. CONCLUSIONS. The combination of PCR amplification of the gene sequences, DGGE analysis, and direct sequencing is a rapid and efficient method for detection of mutations in GA cases. The diversity of the mutations attests to the enormous genetic heterogeneity in this disease.


Assuntos
Atrofia Girata/enzimologia , Ornitina-Oxo-Ácido Transaminase/genética , Alelos , Sequência de Bases , DNA/análise , Análise Mutacional de DNA , Primers do DNA , Eletroforese em Gel de Poliacrilamida , Humanos , Mitocôndrias/enzimologia , Biologia Molecular , Dados de Sequência Molecular , Mutação , Reação em Cadeia da Polimerase , Polimorfismo Genético , Desnaturação Proteica
18.
J Biol Chem ; 267(18): 12950-4, 1992 Jun 25.
Artigo em Inglês | MEDLINE | ID: mdl-1618792

RESUMO

Gyrate atrophy (GA) is an autosomal recessive chorioretinal degenerative disease of the eye caused by an inborn defect of the nuclear encoded mitochondrial enzyme ornithine aminotransferase (OAT). We have described previously a GA patient with a 5.0-kilobase pair truncated EcoRI OAT gene fragment and the absence of OAT mRNA on Northern blot analysis. Cloning and sequencing analysis of the truncated gene fragment revealed a 1,072-base pair (bp) deletion including the entire exon 6, starting in intron 5, 172 bp upstream of exon 6 and ending in intron 6, 772 bp downstream of exon 6. A short direct repeat sequence (AGGAGC), resembling the sequence shown to cause DNA polymerase alpha to pause, and sequences capable of forming hairpin loops were both present at the 5' and 3' break-points of the deletion. Reverse transcription-polymerase chain reaction amplification of the patient's RNA with OAT primers yielded DNA fragments of two different sizes, consistent with a low level expression of OAT mRNA. Direct sequencing of the smaller fragment demonstrated the complete absence of exon 6 sequence in the mRNA predicted from the deletion, causing a reading frame shift which results in a premature termination codon at position 192. The mutation in the other allele has been demonstrated by polymerase chain reaction, denaturing gradient gel electrophoresis, and direct sequencing also to be a premature termination codon in exon 6. The absence of detectable OAT mRNA in this patient is consistent with these premature termination mutations because they have been shown to decrease the level of mRNA, especially if present early in the coding sequence.


Assuntos
Deleção Cromossômica , Atrofia Girata/enzimologia , Ornitina-Oxo-Ácido Transaminase/genética , Sequência de Aminoácidos , Sequência de Bases , Southern Blotting , Clonagem Molecular , DNA , Desoxirribonuclease EcoRI/metabolismo , Atrofia Girata/genética , Humanos , Dados de Sequência Molecular , Ornitina-Oxo-Ácido Transaminase/metabolismo , Reação em Cadeia da Polimerase
19.
J Biol Chem ; 267(5): 3302-7, 1992 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-1737786

RESUMO

Ornithine delta-aminotransferase is a nuclear-encoded mitochondrial matrix enzyme which catalyzes the reversible interconversion of ornithine and alpha-ketoglutarate to glutamate semialdehyde and glutamate. Inherited deficiency of ornithine delta-aminotransferase results in ornithine accumulation and a characteristic chorioretinal degeneration, gyrate atrophy of the choroid and retina. We have surveyed the ornithine delta-aminotransferase genes of gyrate atrophy patients for mutations. Using a variety of techniques, we discovered and molecularly characterized 21 newly recognized ornithine delta-aminotransferase alleles. We determined the consequences of these and three previously described mutations on ornithine delta-aminotransferase mRNA, antigen, and enzyme activity in cultured fibroblasts. The majority (20/24) of these alleles produce normal amounts of normally sized ornithine delta-aminotransferase mRNA. By contrast, only 2/24 had normal amounts of ornithine delta-aminotransferase antigen. Reproducing these mutations by site-directed mutagenesis and expressing the mutant ornithine delta-aminotransferase in Chinese hamster ovary cells confirms that several of these mutations inactivate ornithine delta-aminotransferase and cause gyrate atrophy in these patients.


Assuntos
Atrofia Girata/genética , Mutação , Ornitina-Oxo-Ácido Transaminase/genética , Alelos , Sequência de Aminoácidos , Animais , Sequência de Bases , Células CHO , Linhagem Celular , Cricetinae , Atrofia Girata/enzimologia , Humanos , Dados de Sequência Molecular , Ornitina-Oxo-Ácido Transaminase/metabolismo , Reação em Cadeia da Polimerase , Polimorfismo Genético , Conformação Proteica , Sinais Direcionadores de Proteínas/genética , RNA Mensageiro/genética , Saccharomyces cerevisiae/enzimologia , Homologia de Sequência do Ácido Nucleico , Transfecção
20.
Hum Mutat ; 1(4): 293-7, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1301936

RESUMO

Gyrate atrophy of the choroid and retina (GA) is an autosomal recessive disorder in which a deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (OAT) leads to progressive blindness. Previously, we and others have reported a number of missense mutations and splice defects in the OAT gene associated with GA. In the present case, through sequencing of the PCR amplified cDNA products, we have detected a novel 15-bp deletion within exon 5 of the OAT gene which retains the original reading frame. The deleted PCR product is the only one produced from the patient's mRNA, while mRNA from the patient's mother yields both deleted and normal length PCR products. The alternate, apparently nonexpressing OAT allele in this patient was inherited from the father, who displays only the normal length PCR product. The codon at the deletion joint remains unaltered, predicting the loss of the pentapeptide Tyr-Thr-Val-Lys-Gly without any other amino acid change. The breakpoints are adjacent to or within two copies of a 4-bp direct repeat, which may have implications for the mechanism of deletion.


Assuntos
Atrofia Girata/enzimologia , Atrofia Girata/genética , Ornitina-Oxo-Ácido Transaminase/genética , Deleção de Sequência , Sequência de Aminoácidos , Sequência de Bases , Criança , DNA/genética , Análise Mutacional de DNA , Éxons , Humanos , Masculino , Dados de Sequência Molecular , Ornitina-Oxo-Ácido Transaminase/deficiência , Reação em Cadeia da Polimerase , RNA Mensageiro/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...